KOTAI Biotechnologies

About:

KOTAI Biotechnologies is a research center for bioinformatics and structural analysis.

Website: https://www.kotai-bio.com/jp/

Top Investors: Nissay Capital, Osaka University Venture Capital, Senshu Ikeda Capital

Description:

KOTAI Biotechnologies is a research base that represents immunological bioinformatics and information structural analysis. They conduct research and development with institutions and universities, as well as with business companies such as pharmaceutical companies. They provide for the development of diagnostic and treatment methods. From a routine blood sample, platform technology can reveal the structure and function of immune cell receptors with unprecedented resolution. Repertoire Builder can group receptors according to their target epitopes using sequence and structural features from B or T cell receptor models, revealing the functional landscape of a donor and quantifying differences between donors.

Total Funding Amount:

1.48B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Minoh, Osaka, Japan

Founded Date:

2016-05-30

Founders:

Yamashita Kazuo

Number of Employees:

11-50

Last Funding Date:

2019-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai